Table 4 Cause-specific Cox model on relapse risk.

From: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

 

Cause-specific Cox model on relapse risk

 

HR

P value

Age above 75 years

1.07

0.86

WBC (>10 × 109/l)

7.90

<0.001

ATO/ATRA ± CTX

0.23

0.003

Male gender

0.99

0.99

  1. ATO arsenic trioxide, ATRA all-trans retinoic acid, CTX chemotherapy, HR hazard ratio, OR odds ratio, WBC white blood cell count.
Back to article page